Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05127395 · ClinicalTrials.gov registry record
Impact of Obesity on Clinical Outcomes in Patients Receiving Acyclovir for HSV Encephalitis"
A clinical trial of HSV Encephalitis, sponsored by Methodist Health System.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05127395: Completed study of HSV Encephalitis, sponsored by Methodist Health System.
NCT05127395 is a study of HSV Encephalitis that has completed, run by Methodist Health System. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05127395, a study of HSV Encephalitis, has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Multicenter retrospective chart review of patients admitted to any of the six study centers (SSM Health - St. Clare, St. Mary's, Saint Louis University Hospital, St. Anthony's, St. Mary's Madison, Rush University Medical Center, or Methodist Dallas Medical Center) between January 1, 2013 and December 31, 2019 will be conducted. All study centers utilize Epic ® electronic health record (Verona, Wisconsin; www.epic.com) for which all data will be extracted from. Each study center will obtain individual IRB approval prior to data collection. SSM - St. Clare will serve as the lead center for the study with all other centers sending collected and de-identified data to this central site for analysis.
Primary Outcome
Will assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis
Conditions Studied
Interventions
- OTHER To assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis to definitively guide safe and effective therapy.
Study Locations (1)
Texas
- Methodist Charlton Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2023-04-12 |
What the finished NCT05127395 record still lists
NCT05127395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with HSV Encephalitis appearing as the primary indexed condition, and to 1 intervention - of which To assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis to definitively guide safe and effective therapy. is the first listed.
NCT05127395 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05127395 about?
NCT05127395 is a clinical study titled "Impact of Obesity on Clinical Outcomes in Patients Receiving Acyclovir for HSV Encephalitis"". Multicenter retrospective chart review of patients admitted to any of the six study centers (SSM Health - St. Clare, St. Mary's, Saint Louis University Hospital, St. Anthony's, St. Mary's Madison, Rush University Medical Center, or Methodist Dallas Medical Center) between January 1, 2013 and Decembe...
What is the current status of trial NCT05127395?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-03-09. Estimated completion is 2023-04-12.
What conditions does trial NCT05127395 study?
This clinical trial studies the following conditions: HSV Encephalitis.
What interventions are being tested in trial NCT05127395?
The interventions under investigation include: To assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis to definitively guide safe and effective therapy. (OTHER).
Who is sponsoring clinical trial NCT05127395?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05127395 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI